[06] Session-2: Immuno-Oncology BC -Clinical advances

[1L11] Absolute Lymphocyte Count is a Predictor of Eribulin Efficacy for Advanced or Metastatic Breast Cancer in EMBRACE and Study 301

*Yasuo Miyoshi¹, Yuta Yoshimura², Kenichi Saito³, Kenzo Muramoto², Kenichi Nomoto³ (1. Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan, 2. Eisai Co., Ltd., Koishikawa, Bunkyo-ku, Tokyo, Japan, 3. Eisai Inc., Woodcliff Lake, NJ, USA)